Retinoic Acid Receptor Responder (Tazarotene Induced) 3 (RARRES3) Peptide
Quick Overview for Retinoic Acid Receptor Responder (Tazarotene Induced) 3 (RARRES3) Peptide (ABIN938468)
Target
Origin
Source
Application
-
-
Peptide Type
- Synthetic
-
Sequence
- FSVLSNSAEV KRERLEDVVG GCCYRVNNSL DHEYQPRPVE VIISSAKEMV
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of RARRES3 antibody,
Alternative Names: RARRES3 control peptide, RARRES3 antibody Blocking Peptide, Anti-RARRES3 Blocking Peptide, Retinoic Acid Receptor Responder Blocking Peptide, Tazarotene Induced 3 Blocking Peptide, HRASLS4 Blocking Peptide, MGC8906 Blocking Peptide, RIG1 Blocking Peptide, TIG3 Blocking Peptide, RARRES3, RARRES-3, RARRES 3, RARRES-3 Blocking Peptide, RARRES 3 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- RARRES3 (Retinoic Acid Receptor Responder (Tazarotene Induced) 3 (RARRES3))
-
Background
- Retinoids exert biologic effects such as potent growth inhibitory and cell differentiation activities and are used in the treatment of hyperproliferative dermatological diseases. These effects are mediated by specific nuclear receptor proteins that are members of the steroid and thyroid hormone receptor superfamily of transcriptional regulators. RARRES3 is thought act as a tumor suppressor or growth regulator.
-
Molecular Weight
- 18 kDa
Target
-